T. Sakari Jokiranta
Department of Bacteriology and Immunology
Haartman Institute and HUSLAB
University of Helsinki and Helsinki University Central Hospital
FIN-00290 Helsinki
Finland
Name/email consistency: high
- Where next with atypical hemolytic uremic syndrome? Jokiranta, T.S., Zipfel, P.F., Fremeaux-Bacchi, V., Taylor, C.M., Goodship, T.J., Noris, M. Mol. Immunol. (2007)
- C3b and factor H: key components of the complement system. Jokiranta, T.S. Expert. Rev. Clin. Immunol (2006)
- Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. Jokiranta, T.S., Jaakola, V.P., Lehtinen, M.J., Pärepalo, M., Meri, S., Goldman, A. EMBO J. (2006)
- Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. Jokiranta, T.S., Cheng, Z.Z., Seeberger, H., Jòzsi, M., Heinen, S., Noris, M., Remuzzi, G., Ormsby, R., Gordon, D.L., Meri, S., Hellwage, J., Zipfel, P.F. Am. J. Pathol. (2005)
- Complement C3b interactions studied with surface plasmon resonance technique. Jokiranta, T.S., Westin, J., Nilsson, U.R., Nilsson, B., Hellwage, J., Löfås, S., Gordon, D.L., Ekdahl, K.N., Meri, S. Int. Immunopharmacol. (2001)
- Each of the three binding sites on complement factor H interacts with a distinct site on C3b. Jokiranta, T.S., Hellwage, J., Koistinen, V., Zipfel, P.F., Meri, S. J. Biol. Chem. (2000)
- Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H. Jokiranta, T.S., Solomon, A., Pangburn, M.K., Zipfel, P.F., Meri, S. J. Immunol. (1999)
